Akebia Therapeutics, Inc. (AKBA)
1.34
-0.02
(-1.47%)
USD |
NASDAQ |
Jan 20, 16:00
1.33
-0.01
(-0.75%)
After-Hours: 20:00
Akebia Therapeutics Market Cap: 355.59M for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 178.24B |
| Pfizer Inc. | 145.10B |
| Theravance Biopharma, Inc. | 1.035B |
| Zevra Therapeutics, Inc. | 507.80M |
| Organon & Co. | 2.459B |
Market Cap Related Metrics
| PS Ratio | 1.497 |
| Price to Book Value | 8.549 |
| Price to Free Cash Flow | 10.47 |
| Price | 1.34 |
| Earnings Yield | -5.68% |
| Operating PE Ratio | 18.99 |